The Impact of Aging on Multiple Sclerosis.
Curr Neurol Neurosci Rep
; 24(4): 83-93, 2024 04.
Article
en En
| MEDLINE
| ID: mdl-38416310
ABSTRACT
PURPOSE OF REVIEW Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disorder of the central nervous system. Age is one of the most important factors in determining MS phenotype. This review provides an overview of how age influences MS clinical characteristics, pathology, and treatment. RECENT FINDINGS:
New methods for measuring aging have improved our understanding of the aging process in MS. New studies have characterized the molecular and cellular composition of chronic active or smoldering plaques in MS. These lesions are important contributors to disability progression in MS. These studies highlight the important role of immunosenescence and the innate immune system in sustaining chronic inflammation. Given these changes in immune function, several studies have assessed optimal treatment strategies in aging individuals with MS. MS phenotype is intimately linked with chronologic age and immunosenescence. While there are many unanswered questions, there has been much progress in understanding this relationship which may lead to more effective treatments for progressive disease.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inmunosenescencia
/
Esclerosis Múltiple
Límite:
Humans
Idioma:
En
Revista:
Curr Neurol Neurosci Rep
/
Curr. neurol. neurosci. rep
/
Current neurology and neuroscience reports
Asunto de la revista:
NEUROLOGIA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos